These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16641431)

  • 1. New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.
    Xie LH; Li Q; Lin AJ; Smith K; Zhang J; Skillman DS
    Antimicrob Agents Chemother; 2006 May; 50(5):1649-55. PubMed ID: 16641431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, safety, and hydrolysis of oral pyrroloquinazolinediamines administered in single and multiple doses in rats.
    Li Q; Kozar MP; Shearer TW; Xie LH; Lin AJ; Smith KS; Si Y; Anova L; Zhang J; Milhous WK; Skillman DR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2898-904. PubMed ID: 17562804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats.
    Xie LH; Johnson TO; Weina PJ; Si Y; Haeberle A; Upadhyay R; Wong E; Li Q
    Int J Toxicol; 2005; 24(4):251-64. PubMed ID: 16126619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.
    Guan J; Zhang Q; O'Neil M; Obaldia N; Ager A; Gerena L; Lin AJ
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4928-33. PubMed ID: 16304154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy comparison of intravenous artelinate and artesunate in Plasmodium berghei-infected Sprague-Dawley rats.
    Li QG; Si YZ; Lee P; Wong E; Xie LH; Kyle DE; Dow GS
    Parasitology; 2003 Apr; 126(Pt 4):283-91. PubMed ID: 12741507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
    Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
    Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.
    Ohrt C; Li Q; Obaldia N; Im-Erbsin R; Xie L; Berman J
    Malar J; 2014 Oct; 13():415. PubMed ID: 25336091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats.
    Li Q; Xie LH; Si Y; Wong E; Upadhyay R; Yanez D; Weina PJ
    Int J Toxicol; 2005; 24(4):241-50. PubMed ID: 16126618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-artemisinin combination therapy for malaria.
    Nandakumar DN; Nagaraj VA; Vathsala PG; Rangarajan P; Padmanaban G
    Antimicrob Agents Chemother; 2006 May; 50(5):1859-60. PubMed ID: 16641461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
    Janse CJ; Waters AP; Kos J; Lugt CB
    Int J Parasitol; 1994 Jul; 24(4):589-94. PubMed ID: 8082988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats.
    Li Q; Xie LH; Johnson TO; Si Y; Haeberle AS; Weina PJ
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):104-12. PubMed ID: 16860356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
    Wilairatana P; Viriyavejakul P; Looareesuwan S; Chongsuphajaisiddhi T
    Ann Trop Med Parasitol; 1997 Oct; 91(7):891-6. PubMed ID: 9625947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
    Vivas L; Rattray L; Stewart L; Bongard E; Robinson BL; Peters W; Croft SL
    Acta Trop; 2008 Mar; 105(3):222-8. PubMed ID: 18279817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.
    Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I
    Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial activity of the terpene nerolidol.
    Saito AY; Marin Rodriguez AA; Menchaca Vega DS; Sussmann RAC; Kimura EA; Katzin AM
    Int J Antimicrob Agents; 2016 Dec; 48(6):641-646. PubMed ID: 27742206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent in vivo antimalarial activity of 3,15-di-O-acetylbruceolide against Plasmodium berghei infection in mice.
    Kim HS; Shibata Y; Ko N; Ikemoto N; Ishizuka Y; Murakami N; Sugimoto M; Kobayashi M; Wataya Y
    Parasitol Int; 2000 Jan; 48(3):271-4. PubMed ID: 11227768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activity of Curarea toxicofera in combination with classical antimalarial treatments.
    Rodríguez YV; Arias MH; García JO; Deharo E; Garavito G
    J Ethnopharmacol; 2018 Aug; 222():288-294. PubMed ID: 29626674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation by febrifugine of host defense in mice against Plasmodium berghei NK65.
    Murata K; Takano F; Fushiya S; Oshima Y
    Biochem Pharmacol; 1999 Nov; 58(10):1593-601. PubMed ID: 10535750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.